YS BIOPHARMA CO LTD (YS)

KYG9845F1090 - Common Stock

0.8  +0.01 (+0.63%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-3-31)		 2022
(2021-12-31)		 2021
(2020-12-31)		 2020
(2020-12-31)
ASSETS
Current Assets
Cash
370.11M885.20K885.20KN/A
Marketable Securities
4.34M2.81MN/AN/A
Receivables
468.09M312.74MN/AN/A
Inventories
185.38M166.51MN/AN/A
Other Current Assets
8.06M141.68K141.68KN/A
Total Current Assets
1.04B1.03M1.03MN/A
 
Non-Current Assets
PPE Net
582.89M565.00MN/AN/A
Investments And Advances
N/A200.01M200.01MN/A
Intangibles
78.06M80.72MN/AN/A
Other Non-Current Assets
22.83M0.0091.37K91.37K
Total Non-Current Assets
683.77M200.01M-935.51KN/A
 
TOTAL ASSETS
1.72B201.03M91.37K91.37K
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.005.01K5.01K
Current Portion Of LT Debt.
193.74M111.73MN/AN/A
Accrued Expenses
266.17M142.63K65.00K65.00K
Accounts Payable
80.44M30.81MN/AN/A
Other Current Liabilities
118.42M105.65MN/AN/A
Total Current Liabilities
658.76M142.63K70.01K70.01K
 
Non-Current Liabilities
Long Term Debt
293.79M0.000.000.00
Other Non-Current Liabilities
38.75M20.21M20.21MN/A
Total Non-Current Liabilities
332.54M20.21M0.000.00
 
TOTAL LIABILITIES
991.30M20.35M70.01K70.01K
 
SHAREHOLDERS' EQUITY
Retained Earnings
-1.87B-19.32M-3.64K-3.64K
Additional Paid In Capital
2.66B0.0024.35K24.35K
Common Shares
12.30K200.00M650.00650.00
Other Shareholders' Equity
-54.41M83.09MN/AN/A
Shares Outstanding
93.06M25.75M25.75M25.75M
Tangible Book Value per Share
6.997.020.000.00
Total Shareholders' Equity
728.45M180.68M21.36K21.36K
 
TOTAL LIABILITIES AND EQUITY
1.72B201.03M91.37K91.37K
 
Statistics
Debt/Equity
0.40N/AN/AN/A
Current Ratio
1.577.2014.67N/A
Return On Assets (ROA)
-16.48%-0.27%-3.98%-3.98%
Return On Equity (ROE)
-38.91%-0.30%-17.04%-17.04%

All data in CNY

Charts